Latest Breaking News On - Therapeutics contact - Page 1 : comparemela.com

Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgA Nephropathy

Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgA Nephropathy
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New zealandThomas hutterEmmanuelle lecomte brissetDeric dubeEuropean unionDrug administrationTravere therapeutics incExchange commissionEuropean medicines agencyFresenius medical careEuropean commissionCommittee for medicinal products human useAnnounce sparsentan receives positiveMedicinal productsHuman useTravere therapeutics

Atossa Therapeutics Announces Full Enrollment of (Z)-Endoxifen Arm of I-SPY 2 Clinical Trial

SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innov.

San franciscoUnited statesEric van zantenUniversity of californiaCancer biomarkers consortiumFoundation for the national institutes of healthDrug administrationAtossa therapeutics incSelective estrogen receptor modulatorSteven quayChief executiveQuantum leap healthcare collaborativeNational institutesCancer biomarkersOptimization pilot protocolLeap healthcare collaborative

Avenzo Therapeutics Announces Global License of AVZO-021 (ARTS-021), a Potentially Best-in-Class Clinical Stage CDK2 Inhibitor from Allorion Therapeutics

Avenzo Therapeutics Announces Global License of AVZO-021 (ARTS-021), a Potentially Best-in-Class Clinical Stage CDK2 Inhibitor from Allorion Therapeutics
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesAfshin dowlatiAthena countouriotisUniversity hospitals seidman cancer centerInternational conference on molecularAvenzo therapeutics incEarly phase therapeutics programAllorion therapeutics incTherapeutics announces global licensePotentially best in class clinical stageInvestigational new drugAvenzo therapeuticsAllorion therapeuticsGreater chinaPeter ding

Aclaris Therapeutics Provides Corporate Update

Aclaris Therapeutics Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDouglas manionRoberta doody jrExchange commissionWashington universityAclaris therapeutics incTrial results publishedTrial topline data anticipatedAnnounces reductionEczema areaSeverity indexAclari chief executiveAclaris therapeuticsPrivate securities litigation reform actRisk factorsAclari annual report

Aclaris Therapeutics Announces Patent License Agreement With Sun Pharma For Alopecia

Aclaris Therapeutics Announces Patent License Agreement With Sun Pharma For Alopecia
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

James loeropSun pharmaRoberta doody jrSun pharmaceutical industries incAclaris therapeutics incSun pharmaceutical industriesChief business officerAclaris therapeuticsTherapeutics contactVice president